e-learning
resources
Berlin 2001
Tuesday 25.09.2001
OSA and other sleep related breathing disorders: epidemiology, diagnosis, treatment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
OSA and control of hypertension in stroke
T. E. Wessendorf, Y. M. Wang, A. F. Thilmann, N. Konietzko, H. Teschler (Essen, Germany)
Source:
Annual Congress 2001 - OSA and other sleep related breathing disorders: epidemiology, diagnosis, treatment
Session:
OSA and other sleep related breathing disorders: epidemiology, diagnosis, treatment
Session type:
Oral Presentation
Number:
2360
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. E. Wessendorf, Y. M. Wang, A. F. Thilmann, N. Konietzko, H. Teschler (Essen, Germany). OSA and control of hypertension in stroke. Eur Respir J 2001; 16: Suppl. 31, 2360
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
To code or not to code chronic pulmonary aspergillosis associated malnutrition in PMSI database: that is the problem…
Adherence predictors to positive airway pressure (PAP) treatment in patients with obstructive sleep apnea (OSA)
Related content which might interest you:
OSA and stroke
Source: Sleep and Breathing Conference 2021
Year: 2021
SDB and stroke
Source: ERS Conference
Year: 2015
SAHS and stroke. CPAP compliance and new stroke events
Source: Annual Congress 2011 - Obstructive sleep apnoea: the heart and the brain
Year: 2011
Prevalence of cardiovascular risk factors and coronary artery disease in patients with obstructive sleep apnea syndrome (OSAS) requiring CPAP treatment
Source: Eur Respir J 2006; 28: Suppl. 50, 814s
Year: 2006
Increased incidence of nonfatal cardiovascular events in stroke patients with sleep apnoea: effect of CPAP treatment
Source: Eur Respir J 2012; 39: 906-912
Year: 2012
Prevalence of sleep apnea in ischaemic stroke
Source: Eur Respir J 2006; 28: Suppl. 50, 197s
Year: 2006
The prevalence of obstructive sleep apnea (OSA) in patients with severe asthma and the association between severity of OSA and asthma control
Source: Virtual Congress 2020 – Phenotyping sleep-disordered breathing and its impact on various diseases
Year: 2020
Importance of controlled blood pressure values in a population with obstructive sleep apnea syndrome (OSA) and arterial hypertension (HT)
Source: Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea
Year: 2011
Recommendations for the management of patients with obstructive sleep apnoea and hypertension
Source: Eur Respir J 2013; 41: 523-538
Year: 2013
Correlations between cardiovascular diseases and diabetes in obstructive sleep apnoea (OSA)
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I
Year: 2012
Prevalence of stroke in obstructive sleep apnoea (OSA) patients
Source: Eur Respir J 2007; 30: Suppl. 51, 331s
Year: 2007
Association between obstructive sleep apnoea (OSA) and risk of systemic hypertension in men. A prospective study
Source: Eur Respir J 2003; 22: Suppl. 45, 22s
Year: 2003
Impact of CPAP-therapy on cardiac structure and function in patients with obstructive sleep apnea syndrome and coprevalent arterial hypertension
Source: Eur Respir J 2006; 28: Suppl. 50, 817s
Year: 2006
Adiponectin is not a cardiovascular risk factor in otherwise healthy subjects with obstructive sleep apnea syndrome (OSAS)
Source: Annual Congress 2009 - Cardiovascular complications in obstructive sleep apnoea
Year: 2009
Treating obstructive sleep apnoea to improve control of hypertension
Source: International Congress 2014 – ERS/JAMA lunchtime session: 2014 highlights
Year: 2014
Relationship between age and cardiovascular diseases (CVD) in obstructive sleep apnoea (OSA)
Source: Annual Congress 2008 - Weight control and comorbidity in obstructive sleep apnoea
Year: 2008
Diastolic diurnal hypertension is underestimated in patients with unknown hypertension at time of sleep apnoea diagnosis
Source: Eur Respir J 2003; 22: Suppl. 45, 22s
Year: 2003
Sleep apnoea and systemic hypertension
Source: Eur Respir Mon 2010; 50: 150-173
Year: 2010
Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD
Source: Eur Respir J 2008; 32: 962-969
Year: 2008
Association between arterial hypertension and impaired glucose tolerance (IGT) in obstructive sleep apnoea (OSA) patients
Source: Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept